Search International and National Patent Collections

1. (WO2017202351) NEW CRYSTAL FORM OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR MEDICINE AND PREPARATION METHOD AND USE THEREOF

Pub. No.:    WO/2017/202351    International Application No.:    PCT/CN2017/085813
Publication Date: Fri Dec 01 00:59:59 CET 2017 International Filing Date: Fri May 26 01:59:59 CEST 2017
IPC: C07H 15/14
C07H 1/06
A61K 31/7028
A61P 3/10
Applicants: CRYSTAL PHARMACEUTICAL CO., LTD.
苏州科睿思制药有限公司
Inventors: CHEN, Minhua
陈敏华
ZHANG, Yanfeng
张炎锋
ZOU, Po
邹坡
LIU, Kai
刘凯
ZHANG, Xiaoyu
张晓宇
Title: NEW CRYSTAL FORM OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR MEDICINE AND PREPARATION METHOD AND USE THEREOF
Abstract:
The present invention relates to a new crystal form of a sodium-glucose co-transporter inhibitor medicine (Sotagliflozin) and a preparation method and use thereof. In addition, the present invention relates to a pharmaceutical composition containing the new Sotagliflozin crystal form and a method of using the new Sotagliflozin crystal form and the pharmaceutical composition to treat diseases. The crystal form provided by the present invention has advantageous performances like good stability, relatively low hygroscopicity, exploitability and tractability of process, and the preparation method is simple, is low in cost, and has an important value on the optimization and development of the drug in the future.